BioCentury
ARTICLE | Company News

Egenix cancer news

February 2, 2015 8:00 AM UTC

Egenix filed for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware. Egenix is developing small molecules that inhibit eukaryotic translation initiation factor 4E (eIF4E)...